{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:36Z","timestamp":1787240736347,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["218909"],"award-info":[{"award-number":["218909"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.rmed.2023.107478","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T07:29:14Z","timestamp":1700810954000},"page":"107478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting \u03b22-agonist reliever, as-needed ICS\/formoterol, or ICS\/formoterol maintenance and reliever therapy"],"prefix":"10.1016","volume":"221","author":[{"given":"Nicolas","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Yorganc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7403-3871","authenticated-orcid":false,"given":"Alvaro A.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4268-4960","authenticated-orcid":false,"given":"Gabriel","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PG","family":"Abhijith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurita","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-2336","authenticated-orcid":false,"given":"Swarnendu","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2023.107478_bib1","year":"2023"},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/resp.13389","article-title":"Treatable traits can be identified in a severe asthma registry and predict future exacerbations","volume":"24","author":"McDonald","year":"2019","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2023.107478_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106915","article-title":"The 5T approach in asthma: triple therapy targeting treatable traits","volume":"200","author":"Cazzola","year":"2022","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/all.13629","article-title":"Treatable traits in the European U-BIOPRED adult asthma cohorts","volume":"74","author":"Simpson","year":"2019","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.rmed.2023.107478_bib6","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1513\/AnnalsATS.202011-1386OC","article-title":"Positioning as-needed budesonide-formoterol for mild asthma: effect of prestudy treatment in pooled analysis of SYGMA 1 and 2","volume":"18","author":"Bateman","year":"2021","journal-title":"Annals of the American Thoracic Society"},{"issue":"20","key":"10.1016\/j.rmed.2023.107478_bib7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.rmed.2023.107478_bib8","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O'Byrne","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/resp.12740","article-title":"Effect of smoking status on the efficacy of the SMART regimen in high risk asthma","volume":"21","author":"Pilcher","year":"2016","journal-title":"Respirology"},{"issue":"12","key":"10.1016\/j.rmed.2023.107478_bib11","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.rmed.2007.07.014","article-title":"Budesonide\/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol\/fluticasone","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir. Med."},{"issue":"19","key":"10.1016\/j.rmed.2023.107478_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMoa1511049","article-title":"Serious asthma events with fluticasone plus salmeterol versus fluticasone alone","volume":"374","author":"Stempel","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107478_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaci.2005.11.036","article-title":"Asthma control can be maintained when fluticasone propionate\/salmeterol in a single inhaler is stepped down","volume":"117","author":"Bateman","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2023.107478_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/thoraxjnl-2013-203600","article-title":"Once-daily fluticasone furoate (FF)\/vilanterol reduces risk of severe exacerbations in asthma versus FF alone","volume":"69","author":"Bateman","year":"2014","journal-title":"Thorax"},{"issue":"20","key":"10.1016\/j.rmed.2023.107478_bib15","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaip.2014.02.010","article-title":"Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial","volume":"2","author":"Bleecker","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"9","key":"10.1016\/j.rmed.2023.107478_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/11533450-000000000-00000","article-title":"Treatment comparison of budesonide\/formoterol with salmeterol\/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study","volume":"30","author":"Kuna","year":"2010","journal-title":"Clin. Drug Invest."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1742-1241.2007.01338.x","article-title":"Effect of budesonide\/formoterol maintenance and reliever therapy on asthma exacerbations","volume":"61","author":"Kuna","year":"2007","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.05.00028305","article-title":"Budesonide\/formoterol maintenance and reliever therapy: an effective asthma treatment option?","volume":"26","author":"Vogelmeier","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2023.107478_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.00022010","article-title":"Comparison of two twice-daily doses of budesonide\/formoterol maintenance and reliever therapy","volume":"36","author":"Aubier","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1753465811407236","article-title":"Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide\/formoterol maintenance and reliever therapy regimen?","volume":"5","author":"Aubier","year":"2011","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2023.107478_bib22","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.rmed.2011.02.011","article-title":"Comparing asthma treatment in elderly versus younger patients","volume":"105","author":"Haughney","year":"2011","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2011.10.017","article-title":"Do asthmatic smokers benefit as much as non-smokers on budesonide\/formoterol maintenance and reliever therapy? Results of an open label study","volume":"106","author":"van Schayck","year":"2012","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2023.107478_bib24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.rmed.2006.03.001","article-title":"EXCEL: a randomised trial comparing salmeterol\/fluticasone propionate and formoterol\/budesonide combinations in adults with persistent asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.rmed.2023.107478_bib25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.rmed.2005.09.006","article-title":"Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate","volume":"100","author":"Lundb\u00e4ck","year":"2006","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1185\/030079906X100212","article-title":"Maintenance plus reliever budesonide\/formoterol compared with a higher maintenance dose of budesonide\/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study","volume":"22","author":"Lundborg","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"3","key":"10.1016\/j.rmed.2023.107478_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1752-699X.2010.00217.x","article-title":"Budesonide\/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting","volume":"5","author":"S\u00f8es-Petersen","year":"2011","journal-title":"The clinical respiratory journal"},{"issue":"3","key":"10.1016\/j.rmed.2023.107478_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4046\/trd.2022.0038","article-title":"A pilot randomized trial of as-needed budesonide-formoterol for stepping down controller treatment in moderate asthma with complete remission","volume":"85","author":"Nakwan","year":"2022","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.rmed.2023.107478_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319884387","article-title":"Symptoms and exacerbations in asthma: an apparent paradox?","volume":"10","author":"Morjaria","year":"2019","journal-title":"Therapeutic advances in chronic disease"},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"21","key":"10.1016\/j.rmed.2023.107478_bib32","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.rmed.2023.107478_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107478_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1183\/09031936.00064513","article-title":"Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma","volume":"43","author":"O'Byrne","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2023.107478_bib35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1398-9995.2007.01493.x","article-title":"Beclomethasone\/formoterol vs fluticasone\/salmeterol inhaled combination in moderate to severe asthma","volume":"62","author":"Papi","year":"2007","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S2213-2600(14)70266-8","article-title":"Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial","volume":"3","author":"Papi","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"10202","key":"10.1016\/j.rmed.2023.107478_bib37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1378\/chest.129.2.246","article-title":"Budesonide\/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial","volume":"129","author":"Rabe","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4104\/pcrj.2011.00090","article-title":"Budesonide\/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control","volume":"21","author":"Riemersma","year":"2012","journal-title":"Primary care respiratory journal: journal of the General Practice Airways Group"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/resp.12009","article-title":"Budesonide\/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide\/formoterol plus terbutaline in patients with asthma: phase III study results","volume":"18","author":"Atienza","year":"2013","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.rmed.2023.107478_bib41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1742-1241.2009.02185.x","article-title":"A comparison of budesonide\/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management","volume":"63","author":"Louis","year":"2009","journal-title":"Int. J. Clin. Pract."},{"issue":"9","key":"10.1016\/j.rmed.2023.107478_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1185\/030079904X2051","article-title":"Efficacy and safety of budesonide\/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma","volume":"20","author":"Scicchitano","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"issue":"10","key":"10.1016\/j.rmed.2023.107478_bib43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.rmed.2008.06.017","article-title":"A real-life cost-effectiveness evaluation of budesonide\/formoterol maintenance and reliever therapy in asthma","volume":"102","author":"St\u00e4llberg","year":"2008","journal-title":"Respir. Med."},{"issue":"10109","key":"10.1016\/j.rmed.2023.107478_bib44","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(17)32397-8","article-title":"Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial","volume":"390","author":"Woodcock","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"9537","key":"10.1016\/j.rmed.2023.107478_bib45","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.00104007","article-title":"Budesonide\/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma","volume":"31","author":"Sears","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"546","key":"10.1016\/j.rmed.2023.107478_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3399\/bjgp08X263802","article-title":"Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?","volume":"58","author":"Sovani","year":"2008","journal-title":"Br. J. Gen. Pract.: J. Roy. Coll. Gen. Pract."},{"issue":"8","key":"10.1016\/j.rmed.2023.107478_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/02770903.2011.611954","article-title":"A comparison of budesonide\/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain","volume":"48","author":"Quirce","year":"2011","journal-title":"J. Asthma: official journal of the Association for the Care of Asthma"},{"key":"10.1016\/j.rmed.2023.107478_bib49","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1100\/tsw.2007.134","article-title":"Is there any point in a corticosteroid treatment of intermittent asthma?","volume":"7","author":"Stankovi\u0107","year":"2007","journal-title":"TheScientificWorldJOURNAL"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma","volume":"171","author":"O'Byrne","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2500\/aap.2014.35.3729","article-title":"Budesonide\/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation","volume":"35","author":"Takeyama","year":"2014","journal-title":"Allergy Asthma Proc."},{"issue":"5","key":"10.1016\/j.rmed.2023.107478_bib52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaci.2009.02.034","article-title":"Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide\/formoterol","volume":"123","author":"Pavord","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2023.107478_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12874-021-01310-0","article-title":"Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study","volume":"21","author":"Geissb\u00fchler","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"issue":"8","key":"10.1016\/j.rmed.2023.107478_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13145","article-title":"Understanding of interaction (subgroup) analysis in clinical trials","volume":"49","author":"Brankovic","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"issue":"9209","key":"10.1016\/j.rmed.2023.107478_bib55","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"Assmann","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.rmed.2023.107478_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ahj.2005.04.020","article-title":"Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?","volume":"151","author":"Hern\u00e1ndez","year":"2006","journal-title":"Am. Heart J."},{"issue":"21","key":"10.1016\/j.rmed.2023.107478_bib57","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine--reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.rmed.2023.107478_bib58","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1111\/bcp.15801","article-title":"Modelling Asthma Treatment Responses (MASTER): effect of individual patient characteristics on the risk of exacerbation in moderate or severe asthma: a time-to-event analysis of randomized clinical trials","volume":"89","author":"Oosterholt","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.rmed.2023.107478_bib59","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1007\/s12325-023-02590-2","article-title":"Understanding the clinical implications of individual patient characteristics and treatment choice on the risk of exacerbation in asthma patients with moderate-severe symptoms","volume":"40","author":"Singh","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2023.107478_bib60","unstructured":"Food and Drug Administration, Evaluation and Reporting of Age-, Race-, and Ethnicity-specific Data in Medical Device Clinical Studies, 2017 [Available from:https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance documents\/evaluation-and reporting-age-race-and-ethnicity-specific-data-medical-device-clinical-studies]."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123003669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:09:10Z","timestamp":1767236950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611123003669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":60,"alternative-id":["S0954611123003669"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107478","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting \u03b22-agonist reliever, as-needed ICS\/formoterol, or ICS\/formoterol maintenance and reliever therapy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 GSK. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107478"}}